The Difference Give Finance and Clinical Operations the Same Basis for a Decision

Operon connects the operating record, the cost model and the target in one product workflow. The reason to add it is a repeatable way for the people responsible for the work and the budget to examine the same decision.

For health plans and the partners who run their clinical operations.

Why the connected approach matters

Your Systems Hold the Answer. In Two Places.

Your workflow systems hold the operational records. Your finance systems and reporting support budgeting and review. Your analytics and vendor tools each contribute a perspective. None of that needs replacing.

What is usually missing is one place where the cost model, the target and the recorded work are the same objects for both teams. Without it, a cost-per-case gap is a finance figure, repeat reviews are an operations observation, and the conversation about which one to act on happens across two decks. Operon's contribution is that shared basis, maintained as a product workflow rather than rebuilt for each review.

1 · Recorded by operations

Case UM-2026-000731 · what happened

1IntakeJul 3
2Clinical Review · human reviewJul 3 – 8
3Clinical Review · re-entry · AI-assistedJul 11 – 14
4Decision · automated preparationJul 14 – 18

Visits, re-entries and actions from the workflow system. No dollars yet; recorded activity supplied by the workflow data.

2 · Priced by the cost model

Agreed prices, applied to each recorded fact

Base cost · once per case
$6.00
4 visits · standard cost per step
$31.00
Human Review · 2 occurrences
+$7.00
AI-assisted, automated · 2 occurrences
−$6.00
Modeled case cost
$38.00

Prices reviewed by finance, tied to the workflow version they were set against. Change a price and every case reprices the same way.

3 · Read by finance

Cost per case by month, against the goal

Modeled
$31.50
per case · 1.64M cases · $51.7M
Goal · Sep 30
$30.00
gap +$1.50 · +$2.5M Jan – Aug
Historical → goal
85%
$8.50 of $10.00
$40 $36 $32 $28 HISTORICAL FY2025 · $40.00 OPERATIONAL GOAL $30.00 · SEP 30 $32.60 AUG · 208K CASES · $31.20 Jan Feb Mar Apr May Jun Jul Aug
Current Process ModelHistoricalGoal

Inspect the recorded work, the cost rules and the selected target behind the +$1.50 gap.

The economics are finance's. The facts underneath are operations'. One record carries both, so a +$1.50 gap arrives with the cases, cost rules and target behind it.

What Operon contributes

The Model, the Target and the Record, Kept Together for the Same Decision.

Each of these may exist somewhere in your stack today. Together they let you examine a cost target, investigate its operational drivers, or evaluate proposed rates using the same recorded work.

What you may already have
Operon's contribution
When the addition matters

Cost figures in finance reporting; targets in a planning spreadsheet

Cost models and targets as product objects

A price list per kind of recorded fact and a cost-per-case target with step shares, reviewed by finance and tied to a workflow version, rather than recomputed for each meeting.

When the target is debated more than once a year and the step owner needs a number for their step, not a program average.

Case status and queue reports from the workflow system

Recorded operational evidence, priced

Ownership, waiting, repeat work and service risk stay visible as management facts. The same recorded activity carries its modeled cost.

When operations sees repeat reviews and finance sees a cost gap, and both need to examine whether that pattern contributes to the variance before choosing an improvement priority.

Drilldowns in BI, built per request

Case-level explanations, on demand

Every monthly figure opens the cases behind it; every case shows base cost plus each recorded visit and action, in order.

When "why did August move?" has to be answered in the meeting, not three weeks after it.

Vendor proposals and AI business cases in their own spreadsheets

Model comparison on the same recorded history

Copy the price list, change an assumption, reprice last year’s cases. Same-history repricing compares cost assumptions; it does not simulate how a new process would perform.

When a rate card or an AI step is being evaluated and finance and operations want it priced on your own cases before anyone commits.

If you run process intelligence or a mature analytics team, your current tools may already do some or all of this. The question is not whether the result can be reproduced elsewhere; it is whether keeping these capabilities together, as a routine finance and operations both use, is worth adding for the workflow and management cadence you have. That is a fit question, and we treat it as one.

One example · Prior Authorization

A $1.50 Gap. Is It the Prices, the Work, or Both?

Modeled cost per case is $31.50 against a $30.00 target. Read by step, Clinical Review contributes $16.40 against its $15.00 share. The same row is what finance and the review owner both look at next.

Gap to goal, by workflow step

Modeled contribution against each step's share of the $30.00 goal.

Illustrative PA model figures
Step · modeled vs shareunderoverper casea year
Intake$4.20 vs $5.00−$0.80−$2.0M
Clinical Review$16.40 vs $15.00+$1.40+$3.5M
Decision$2.90 vs $4.00−$1.10−$2.75M
Outside targeted steps$8.00 vs $6.00+$2.00+$5.0M
Gap to goal$31.50 vs $30.00Scale ±$2.00 · bars sum to the gap+$1.50+$3.75M

Modeled, not reconciled. Prices reviewed by finance applied to recorded activity. Not reconciled expense or medical spend; a lower modeled cost is not, by itself, a verified saving. In this example finance set the $30.00 goal and the Clinical Review owner carries the $15.00 share.

Finance

Checks the price model and the target

Is $15.00 the right share for Clinical Review? Are the prices for a standard review and a re-entry still the ones the plan agreed? Two of eight actions are unpriced; does that change the reading?

Clinical Review owner

Inspects the case activity behind $16.40

Which cases re-entered review, from where, and how often. Which of those patterns merit investigation and which reflect clinically necessary second looks. Service risk and clinical judgment stay with the owner.

The joint decision: does the $1.40 reflect model prices, recorded work, or both, and which investigation comes first. One record gives both teams a common place to inspect the evidence, resolve questions, and choose the next investigation.

When it fits

What Has to Be in Place. And When It Already Is.

Identifiable workflow history

Cases, steps and actions that can be followed across the systems involved. Coverage and freshness set which questions the record can answer.

A workflow owner

Someone responsible for the step or workflow who will look at the evidence and decide what merits investigation. The tool does not make that call.

Reviewed cost-model inputs

Prices finance has reviewed. A flat model is a legitimate first model; missing prices and coverage need review before the result is read.

Worth exploring when a cost target, a rate comparison or an improvement claim is being debated between finance and operations, and the two sides are working from different numbers.

Probably not needed when your current setup already gives the decision the traceability and recurring review it needs, and both teams accept its numbers without a second reconciliation.

Next Step

Discuss Where Operon Would Add Value.

Bring one decision and how you answer it today. We will talk through the evidence you already have, whether the connected approach changes that decision, and what a useful next step would require, if there is one.

See the PA Cost-Gap Example

No customer data is needed to review it.

Book a Call

  • 30 minutes with our founding team
  • One decision you are working on, and the numbers each side uses for it today
  • A straight answer on whether adding Operon would change that decision